Autobio Diagnostics Co., Ltd. (SHA:603658)
China · Delayed Price · Currency is CNY 35.00
+0.60 (1.74%)
At close: Mar 6, 2026
Autobio Diagnostics Market Cap
Autobio Diagnostics has a market cap or net worth of 20 billion as of March 6, 2026. Its market cap has decreased by -14.65% in one year.
Market Cap
20.00B
Enterprise Value
19.29B
Revenue
4.22B
Ranking
n/a
PE Ratio
18.24
Stock Price
35.00
Market Cap Chart
Since September 1, 2016, Autobio Diagnostics's market cap has increased from 8.82B to 20.00B, an increase of 126.76%. That is a compound annual growth rate of 8.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 20.00B | -1.19% |
| Dec 31, 2025 | 20.24B | -18.93% |
| Dec 31, 2024 | 24.97B | -24.62% |
| Dec 29, 2023 | 33.12B | -8.65% |
| Dec 30, 2022 | 36.26B | 12.33% |
| Dec 31, 2021 | 32.28B | -50.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| APT Medical | 32.57B |
| Lepu Medical Technology (Beijing) | 31.19B |
| MGI Tech | 23.25B |
| Double Medical Technology | 18.46B |
| MeHow Innovative | 16.72B |
| Shandong Weigao Blood Purification Products | 16.19B |
| Jafron Biomedical | 14.70B |
| Beijing Balance Medical Technology | 14.13B |